Skip to main content
Erschienen in: Rheumatology International 2/2019

Open Access 20.08.2018 | Observational Research

Raynaud’s phenomenon in Northern Sweden: a population-based nested case–control study

verfasst von: Albin Stjernbrandt, Hans Pettersson, Ingrid Liljelind, Tohr Nilsson, Jens Wahlström

Erschienen in: Rheumatology International | Ausgabe 2/2019

Abstract

The aim of this study was to determine the association between individual and external exposure factors, and the reporting of Raynaud’s phenomenon, with or without concomitant cold sensitivity. In a population-based nested case–control study, cases with Raynaud’s phenomenon (N = 578), and matched controls (N = 1156), were asked to respond to a questionnaire focusing on different risk factors. Univariate and multiple conditional logistic regression were performed. Analyses were stratified according to whether the cases reported cold sensitivity or not. In total, 1400 out of 1734 study subjects answered the questionnaire (response rate 80.7%). In the final multiple model, the factor with the strongest association to Raynaud’s phenomenon, with and without cold sensitivity, was previous frostbite affecting the hands (OR 12.44; 95% CI 5.84–26.52 and OR 4.01; 95% CI 1.78–9.01, respectively). Upper extremity nerve injury was associated to reporting Raynaud’s phenomenon and cold sensitivity (OR 2.23; 95% CI 1.29–3.85), but not Raynaud’s phenomenon alone. Reporting any exposure to hand-arm vibration or cumulative cold exposure was significant in univariate analyses for cases with both Raynaud’s phenomenon and cold sensitivity, but not in the multiple model. Raynaud’s phenomenon is strongly associated to previous cold injury, with a larger effect size among those who also report cold sensitivity. The fact that only upper extremity nerve injury differed significantly between case groups in our multiple model offers additional support to the neural basis for cold sensitivity.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00296-018-4133-y) contains supplementary material, which is available to authorized users.

Introduction

Raynaud’s phenomenon

Raynaud’s phenomenon (RP) is a common condition, characterized by attacks of peripheral blanching of digits, which can be triggered by exposure to cold, vibration, or emotional stress [1]. It occurs in a primary form (Raynaud’s disease) that mostly affects younger women, and in a secondary form (Raynaud’s syndrome) that is related to rheumatic disease, hematological conditions, occlusive arterial disease, hand-arm vibration (HAV) syndrome, as well as certain chemicals and therapeutic drugs [2]. The secondary form of RP has also been reported as a sequela to cold injury [3]. Having a severe manifestation of RP can affect the activities of daily living [4] and hinder outdoor leisure activities. Primary RP seldom progress to more severe stages of disease [5], while the prognosis of secondary RP is highly dependent on the treatment of the underlying cause. In a recent review, the prevalence of primary RP has been estimated to 0.8–6.5% of men and 2.1–15.8% of women [1]. In a previous study by our group, the prevalence of RP in Northern Sweden was 11.0% of men, and 14.0% of women [6]. We have also shown that RP overlaps heavily with another cold-related symptom, here denoted cold sensitivity (CS) [7].

Cold sensitivity

CS has been defined as a collection of acquired symptoms resulting in an abnormal aversion to cold with pain, sensory alterations, stiffness and/or color changes, which may occur after a traumatic injury [8]. Other terms such as cold intolerance and cold hypersensitivity have been used interchangeably. CS primarily affects the hands, and is often distinguished from RP by the fact that there is no clinically observable vasospasm present in CS, which is mandatory for a firm diagnosis of RP. CS has predominantly been studied in relation to different types of hand injuries, such as hand or digital amputation [9], nerve injury [10], arterial injury [11], or hand-arm vibration syndrome [12]. It has also been described in relation to certain systemic diseases, such as diabetes mellitus [13] and rheumatic disease [14]. However, the pathophysiological mechanism remains to be fully described. The clinical diagnosis of CS is most often based solely on the symptoms reported by the patient, and can be summarized by using the Cold Intolerance Symptom Severity (CISS) questionnaire [15]. Being sensitive to cold can have a profound impact on quality of life and work ability [9]. The literature on the prevalence of CS in the general population is scarce, and highly dependent upon the definition used. Recent Swedish studies have reported a prevalence between 4.9 and 14.4% in the general population [6, 12]. There is a need to establish common and separating factors for RP and CS to offer clues to the pathophysiological basis for the overlap between the conditions.

Objective

The objective of this study was to determine the association between individual and external exposure factors, and the reporting of RP. We also wanted to distinguish between RP cases who concomitantly reported CS from those who did not.

Methods

Study design

The present study was a nested case–control study on subjects reporting RP and matching controls. The cases were stratified according to the reporting of concomitant CS or not.

Setting

The study was carried out in the four northernmost counties in Sweden: Norrbotten; Västerbotten; Västernorrland; and Jämtland. The study region held a population of approximately 880,000 people, and is located between the 62°N and 69°N latitude, with a mixed subarctic and temperate climate.

Participants

The first data collection, here titled CHINS1, was initiated on the 5th of February and ended on the 5th of May, 2015. It consisted of a questionnaire-based study performed on a sample of men and women between ages 18 and 70 years living in the study area. The study sample was selected from the national Swedish population register. The data collection has previously been thoroughly described [6].
From the collected baseline data, cases with RP were identified through the use of a single questionnaire item: “Does one or more of your fingers turn white (as shown on picture) when exposed to moisture or cold?”, that was supported by a standardized color chart, which previously has been shown to increase the accuracy in RP diagnosis [16]. Those who answered yes fulfilled the case definition.
In the group that had reported RP, we also investigated whether these subjects simultaneously fulfilled our definition of CS [7], which was based on two questionnaire items:
1.
“I am oversensitive to cold” to which the study participant could answer on a fixed numerical scale ranging from 1 (“do not agree”) to 10 (“agree completely”). An answer of 4 or more was considered a positive response.
 
2.
“I experience pain/discomfort when fingers/hands are exposed to cold” to which the study participant could answer on a four-grade scale, in the form of “none”, “insignificant”, “somewhat” or “a lot”. Answering “a lot” was considered a positive response.
 
A positive response on both questions fulfilled our definition for CS.
All subjects that reported both RP and CS were invited to a second data collection, here titled CHINS2. We also invited a similarly sized group of randomly selected subjects which had reported RP but negated CS. This approach was used to be able to stratify cases reporting RP on the basis of concomitant CS, to establish any distinguishing factors.
Controls were randomly selected with a ratio of 2:1 among study subjects from the CHINS1 cohort according to the following inclusion criteria:
1.
No reported RP;
 
2.
No reported CS;
 
3.
Matching the case with regard to geographical area, sex, and age (± 2 years).
 
The second, CHINS2 study, was initiated on the 10th of October, 2015, and ended on the 10th of March, 2016. Cases and controls received the same questionnaire. A flowchart of the data collection is presented in Fig. 1.
The study protocol was approved by the Regional Ethical Review Board situated at Umeå University (DNR 2015-24-31M and 2014-286-31M).

Variables

The study questionnaire collected data on place of livelihood, sex, age, height, and weight. Geographical location was determined by postal code and subsequently categorized into three groups: coastal, inland, and alpine. The occupations of the study participants were coded in accordance with the International Standard Classification of Occupations [17].
To quantify the severity of CS, we added a 100 mm visual analogue scale (VAS) [18], where the study participants were asked to mark the extent of problems with their hands they experience when exposed to cold climate. We also included the Swedish version of the Cold Intolerance Symptom Severity (CISS) questionnaire [15]. This inventory scores subjective problems with ambient cold exposure on a scale ranging from 4 to 100, where a value exceeding 50 has been suggested to indicate abnormal CS [19].
Frostbite affecting the hands was categorized as first degree (white spots), second degree (blisters), or third degree (blood-filled blisters) according to a previous definition [20]. Other questions asked if the study participants had been diagnosed by a physician for any of the following: hypertension; angina pectoris; myocardial infarction; stroke; diabetes mellitus; joint disease; or migraines. Questions were also posed about the presence of rheumatic disease, upper extremity nerve injury, polyneuropathy, carpal tunnel syndrome, and peripheral vascular disease, and the study participants were asked to specify the condition in detail (in free text). The rheumatic diseases included were systemic sclerosis, CREST syndrome, rheumatoid arthritis, juvenile rheumatoid arthritis, reactive arthritis, unspecified arthritis, systemic lupus erythematosus, psoriatic arthritis, ankylosing spondylitis, Sjögren’s syndrome, Ehlers–Danlos syndrome, fibromyalgia, gout, polymyositis, dermatomyositis, Dercum’s disease, and mixed connective tissue disease.
The use of therapeutic drugs was collected in free text, and coded by one of the study physicians (AS) into two broad categories based on whether the substance has a documented negative effect on either peripheral nerves [21] or circulation [22]. Beta-adrenergic antagonists, as well as oral contraceptives and hormone replacement therapies, were also analyzed separately.
Ambient cold exposure was investigated with several questions, partly rephrased from the Potential Work Exposure Scale [23]. For example, study participants were asked if their work required them to manually handle objects with a temperature near or below freezing. They were also asked to grade their occupational and leisure-time cold exposure on a fixed numerical rating scale (NRS) ranging from 1 to 10, respectively. The two scales were subsequently added together to form a cumulative measurement of cold exposure ranging from 2 to 20, as has been done earlier [7]. For HAV, the study participants were asked to specify if they had recurrent occupational exposure to impact tools, high-frequency tools, forestry and gardening equipment, vibrating tools, heavily vibrating tools, or operating vehicles with vibrating controls.

Statistical methods

Cases reporting RP were stratified on the basis of reporting concomitant CS, and analyzed separately with matching controls as reference. Characteristics for cases and controls were described as means and standard deviation (SD) for continuous variables, and as numbers and percentages for categorical variables. Missing data were excluded from all analyses. Numerical rating scales for occupational and leisure-time, as well as for cumulative cold exposure, were dichotomized into high or low exposure based on the 50th percentile.
The statistical association for each candidate factor was assessed separately using univariate conditional logistic regression, and presented as an odds ratio (OR) with 95% confidence interval (95% CI) for reporting RP (Tables 2, 3). In these analyses, p values less than 0.05 were considered statistically significant. Sex-specific subgroup analyses were also conducted. Thereafter, multiple conditional logistic regression was used to investigate the relationships between and identify the most important associated factors using a manual forward stepwise procedure. For this model, all factors with a p value less than 0.25 in the univariate analyses were tested. In each step, the associated factor with the lowest p value when entered into the model was included, and the remaining factors that had not been included were all tested again in the next step. The procedure was stopped when no factor with a p value less than 0.25 when added to the model remained available. Variables with missing data > 15% were not eligible for the multiple model.

Results

Participants

The CHINS2 questionnaire was sent out to 289 cases reporting RP and CS, of which 239 were returned (response rate 82.7%). An additional 289 cases that had only reported RP also received the same questionnaire, and 244 responded (84.4%). For the matched controls, 1156 subjects were asked to participate, and 917 returned the questionnaire (79.3%). From both groups of cases, 11 subjects were excluded for lacking at least one responding matching control. Also, 154 controls were excluded for lacking a matching case. Therefore, the final study population consisted of 1224 subjects, of which 228 were cases reporting RP and CS, 233 cases reporting only RP, and 763 matching controls (Fig. 1). The amount of missing data varied between 0.8 and 5.1% between questionnaire items, except for the free text question regarding therapeutic drug use, which had a larger proportion (25.0%).

Study population characteristics (Table 1)

Table 1
Descriptive data on study participants, presented as numbers (N) and column percentages (%)
 
RP cases with CS
RP cases without CS
Controls
N
%
N
%
N
%
Responders
228
 
233
 
763
 
Sex
 Men
90
39.5
90
38.6
308
40.4
 Women
138
60.5
143
61.4
455
59.6
Age group
 18–29
16
7.0
7
3.0
32
4.2
 30–39
16
7.0
15
6.4
50
6.6
 40–49
52
22.8
41
17.6
147
19.3
 50–59
70
30.7
64
27.5
212
27.8
 60–70
74
32.5
106
45.5
322
42.2
Geographical region
 Alpine
51
22.4
51
21.9
165
21.6
 Inland
67
29.4
54
23.2
206
27.0
 Coastal
110
48.2
128
54.9
392
51.4
Cold sensitivity measures
 CISS > 50
96
50.3
4
2.1
33
5.9
 CISS ≤ 50
95
49.7
185
97.9
526
94.1
 VAS > 50
211
95.5
91
41.6
166
22.7
 VAS ≤ 50
10
4.5
128
58.4
566
77.3
Occupation
 Managers
6
2.8
11
4.8
27
3.6
 Professionals
46
21.1
44
19.4
115
15.4
 Technicians and associate professionals
21
9.6
31
13.7
75
10.1
 Clerical support workers
22
10.1
20
8.8
68
9.1
 Service and sales workers
29
13.3
23
10.1
115
15.4
 Skilled agricultural, forestry, and fishery workers
3
1.4
3
1.3
13
1.7
 Crafts and related trades workers
10
4.6
11
4.8
26
3.5
 Plant and machine operators and assemblers
19
8.7
11
4.8
43
5.8
 Elementary occupations
2
0.9
4
1.8
15
2.0
 Armed forces occupations
2
0.9
0
0.0
2
0.3
 Self-employed
5
2.3
5
2.2
14
1.9
 Students
5
2.3
4
1.8
11
1.5
 Unemployed
2
0.9
2
0.9
15
2.0
 Parental leave
0
0.0
0
0.0
2
0.3
 Sick leave
5
2.3
2
0.9
13
1.7
 Retired
41
18.8
56
24.7
192
25.7
RP Raynaud’s phenomenon, CS cold sensitivity, CISS cold intolerance symptom severity score, VAS visual analogue scale
There was a predominance of women among cases reporting both RP and CS (N = 138; 60.5%), and cases reporting only RP (N = 143; 61.4%). The mean age was 52.5 years (SD 12.5) for cases reporting both RP and CS and 55.8 years (SD 11.4) for cases only reporting RP. The mean age at which attacks of RP debuted was 31.0 years (SD 15.5; range 4–69) in the group reporting both RP and CS, and 33.0 years (SD 14.6; range 4–66) in the group reporting only RP. The CISS score was generally higher among cases reporting both RP and CS (mean 50.2; SD 15.9) compared to cases only reporting RP (mean 23.8; SD 11.1) and controls (mean 21.3; SD 14.3). For the VAS rating, cases reporting RP and CS had a higher value (mean 80.6 mm; SD 17.4) compared to cases with only RP (mean 41.1 mm; SD 25.2), which in turn was higher than among controls (mean 28.0 mm; SD 27.0).

Univariate analyses (Tables 2, 3)

Table 2
Univariate conditional logistic regression of individual factors suggested to be associated with Raynaud’s phenomenon and cold sensitivity, including body mass index, heredity, tobacco use, therapeutic drug use, diseases, and injuries
Factor
Exposure level
RP cases with CS (N = 228)
Controls (N = 379)
RP cases without CS (N = 233)
Controls (N = 384)
N
%
OR
95% CI
N
%
N
%
OR
95% CI
N
%
BMI
BMI < 18.5
2
0.9
0.99
0.16–6.02
3
0.8
1
0.4
0.35
0.03–3.59
3
0.8
18.5 ≤ BMI < 25
144
64.0
1
155
41.8
125
54.8
1
143
38.4
BMI ≥ 25
79
35.1
0.37*
0.25–0.54
213
57.4
102
44.7
0.50*
0.35–0.71
226
60.8
Heredity
 Raynaud’s phenomenona
Yes
75
33.8
3.90*
2.49–6.11
41
11.2
83
37.4
5.03*
3.11–8.15
41
11.1
No
147
66.2
1
324
88.8
139
62.6
1
329
88.9
Tobacco use
 Daily tobacco use
Yes
52
22.8
1.40
0.93–2.11
66
17.5
59
25.5
1.45
0.97–2.17
81
21.6
No
176
77.2
1
311
82.5
172
74.5
1
294
78.4
Therapeutic drug use
 Affecting peripheral nervesb
Yes
23
12.6
0.92
0.46–1.84
37
13.9
24
14.3
0.72
0.41–1.27
56
19.9
No
160
87.4
1
230
86.1
144
85.7
1
226
80.1
 Affecting peripheral circulationc
Yes
41
22.9
1.53
0.88–2.67
54
20.8
30
18.2
1.23
0.69–2.22
48
17.1
No
138
77.1
1
206
79.2
135
81.8
1
232
82.9
Diseases and injuries
 Vascular diseased
Yes
27
12.9
1.79*
1.01–3.19
28
7.7
26
11.4
1.49
0.81–2.74
31
8.5
No
183
87.1
1
336
92.3
202
88.6
1
334
91.5
 Diabetes mellitus
Yes
8
3.6
0.77
0.33–1.78
19
5.1
6
2.6
0.48
0.19–1.24
22
5.8
No
217
96.4
1
354
94.9
225
97.4
1
355
94.2
 Migraines
Yes
32
14.3
1.96*
1.14–3.36
30
8.1
16
7.0
0.67
0.37–1.21
39
10.4
No
192
85.7
1
341
91.9
211
93.0
1
335
89.6
 Rheumatic diseasee
Yes
15
7.1
2.05
0.99–4.25
14
3.8
6
2.6
1.08
0.51–2.29
10
2.7
No
196
92.9
1
351
96.2
216
97.3
1
362
97.3
 Carpal tunnel syndrome
Yes
22
10.0
1.24
0.67–2.30
31
8.4
20
8.7
1.40
0.74–2.64
26
6.9
No
198
90.0
1
339
91.6
209
91.3
1
350
93.1
 Polyneuropathy
Yes
7
3.2
5.58*
1.12–27.79
3
0.8
0
0
0.03
0.00–18.71
7
1.8
No
215
96.8
1
362
99.2
225
100.0
1
374
98.2
 Upper extremity nerve injury
Yes
73
32.7
2.09*
1.42–3.09
72
19.4
46
20.4
1.17
0.77–1.79
65
17.1
No
150
67.3
1
300
80.6
180
79.6
1
316
82.9
 Frostbite handsf
Yes
89
39.2
13.13*
6.79–25.40
23
6.1
36
15.6
4.26*
2.23–8.12*
15
4.0
No
138
60.8
1
354
93.9
195
84.4
1
364
96.0
OR odds ratio, 95% CI 95% confidence interval, RP Raynaud’s phenomenon, CS cold sensitivity, BMI body mass index
*Bold values indicate odds ratios with significant 95% confidence intervals
aFirst-degree relative (parent, sibling or child) with Raynauds phenomenon, indicating a positive family history
bStatins, antibiotics, immunosuppressive drugs, antineoplastic agents, amiodarone, dapsone, phenytoin and/or hydralazine
cBeta-adrenergic antagonists, interferons, oral contraceptives and hormone replacement therapies, antineoplastic agents, sympathomimetics drugs, lithium, clonidine, and/or ergotamine
dHypertension, angina pectoris, myocardial infarction, stroke, and/or peripheral vascular disease
eSystemic sclerosis, CREST syndrome, rheumatoid arthritis, juvenile rheumatoid arthritis, reactive arthritis, unspecified arthritis, systemic lupus erythematosus, psoriatic arthritis, ankylosing spondylitis, Sjögren’s syndrome, Ehlers–Danlos syndrome, fibromyalgia, gout, polymyositis, dermatomyositis, Dercum’s disease, and/or mixed connective tissue disease
fThe majority (> 94.0%) reported first degree injuries
Table 3
Univariate conditional logistic regression of external exposure factors suggested to be associated with Raynaud’s phenomenon and cold sensitivity, including cold exposure and hand-arm vibration measures
Factor
Exposure level
RP cases with CS (N = 228)
Controls (N = 379)
RP cases without CS (N = 233)
Controls (N = 384)
N
%
OR
95% CI
N
%
N
%
OR
95% CI
N
%
Cold exposure measures
 Occupational cold exposurea (NRS 1–10)
High (NRS > 1)
110
50.7
1.44
0.995–2.09
144
40.1
84
37.7
1.15
0.78–1.71
131
36.1
Low (NRS 1)
107
49.3
1
215
59.9
139
62.3
1
232
63.9
 Leisure-time cold exposureb (NRS 1–10)
High (NRS > 5)
120
54.1
1.11
0.79–1.57
185
49.6
127
56.2
1.48*
1.04–2.12
177
47.3
Low (NRS ≤ 5)
102
45.9
1
188
50.4
99
43.8
1
197
52.7
 Cumulative cold exposurec (NRS 2–20)
High (NRS > 8)
123
57.5
1.47*
1.03–2.09
160
44.9
96
43.4
1.12
0.77–1.64
149
41.3
Low (NRS ≤ 8)
91
42.5
1
196
55.1
125
56.6
1
212
58.7
 Handling cold objects during work
Yes
74
33.3
3.06*
1.92–4.90
61
16.4
45
19.7
1.09
0.70–1.72
70
18.5
No
148
66.7
1
311
83.6
184
80.3
1
308
81.5
 Extreme cold, wind or cooling moisture during work
Yes
81
36.2
2.41*
1.53–3.79
88
23.7
55
23.9
0.94
0.62–1.43
93
24.6
No
143
63.8
1
284
76.3
175
76.1
1
285
75.4
Occupational HAV exposure measures
 Impact tools
Yes
39
17.4
2.60*
1.49–4.54
28
7.5
30
13.1
1.49
0.86–2.58
34
9.0
No
185
82.6
1
344
92.5
199
86.9
1
344
91.0
 Rapidly rotating tools
Yes
7
3.2
2.00
0.62–6.41
5
1.3
8
3.5
1.13
0.43–3.02
10
2.7
No
215
96.8
1
366
98.7
219
96.5
1
366
97.3
 Forestry/gardening tools
Yes
35
15.8
1.40
0.80–2.45
50
13.5
33
14.7
1.18
0.69–2.04
48
12.7
No
187
84.2
1
321
86.5
192
85.3
1
329
87.3
 Vibrating tools
Yes
44
19.6
2.21*
1.29–3.76
40
10.8
39
17.0
1.49
0.91–2.44
46
12.3
No
180
80.4
1
330
89.2
190
83.0
1
329
87.7
 Heavily vibrating tools
Yes
39
17.5
2.81*
1.52–5.19
32
8.6
34
14.8
2.13*
1.21–3.74
29
7.7
No
184
82.5
1
338
91.4
196
85.2
1
348
92.3
 Vehicles with vibrating controls
Yes
34
15.2
1.94*
1.11–3.38
36
9.7
28
12.2
1.21
0.68–2.16
39
10.4
No
189
84.8
1
336
90.3
201
87.8
1
335
89.6
 Any HAV exposured
Yes
67
31.0
1.98*
1.23–3.19
79
21.5
54
24.1
1.19
0.76–1.86
78
21.1
No
149
69.0
1
289
78.5
170
75.9
1
291
78.9
OR odds ratio, 95% CI 95% confidence interval, RP Raynaud’s phenomenon, CS cold sensitivity, BMI body mass index, NRS numerical rating scale, HAV hand-arm vibration
*Bold values indicate odds ratios with significant 95% confidence intervals
aSelf-estimated occupational cold exposure, reported on a ten-point numerical rating scales (NRS), where a value above the 50th percentile (NRS > 1) was denoted high, while a value below (NRS 1) was denoted low
bSelf-estimated leisure-time cold exposure, reported on a ten-point numerical rating scales (NRS), where a value above the 50th percentile (NRS > 5) was denoted high, while a value below (NRS ≤ 5) was denoted low
cSelf-estimated occupational and leisure-time cold exposure, reported on two separate ten-point numerical rating scales (NRS), were added together to form a cumulative measurement of cold exposure ranging from 2 to 20, and a value above the 50th percentile (NRS > 8) was denoted high, while a value below (NRS ≤ 8) was denoted low
dAny recurrent occupational hand-arm vibration (HAV) exposure, including use of impact tools, rapidly rotating tools, forestry and gardening tools, vibrating tools, heavily vibrating tools, and/or vehicles with vibrating controls
In the univariate conditional logistic regression analyses, heredity for RP was significantly associated with reporting RP and CS (OR 3.90; 95% CI 2.49–6.11), as well as only reporting RP (OR 5.03; 95% CI 3.11–8.15), compared to controls. Previous frostbite was also significantly associated with reporting RP and CS (OR 13.13; 95% CI 6.79–25.40), and only RP (OR 4.26; 95% CI 2.23–8.12). A high BMI (≥ 25 kg/m2) showed an inverse relationship to reporting RP and CS (OR 0.37; 0.25–0.54), and only RP (OR 0.50; 0.35–0.71).
Diseases and injuries that were statistically significant among cases reporting RP and CS were: vascular disease (OR 1.79; 95% CI 1.01–3.19); migraines (OR 1.96; 95% CI 1.14–3.36); polyneuropathy (OR 5.58; 95% CI 1.12–27.79); and upper extremity nerve injury (OR 2.09; 95% CI 1.42–3.09); none of these variables were significant among cases reporting only RP. The use of therapeutic drugs with negative effects on peripheral nerves or circulation did not show any significant association to reporting of RP; nor did beta-adrenergic antagonists, or oral contraceptives and hormone replacement therapies, when analyzed separately (data not shown).
Among external exposures, variables that were statistically significant among cases reporting RP and CS were: cumulative cold exposure above the 50th percentile (OR 1.47; 95% CI 1.03–2.09); handling cold objects during work (OR 3.06; 95% CI 1.92–4.90); being exposed to extreme cold, wind or cooling moisture during work (OR 2.41; 95% CI 1.53–3.79); and being exposed to any type of occupational HAV (OR 1.98; 95% CI 1.23–3.19); none of these variables were significant among cases reporting only RP.

Multiple model

In the final multiple model for cases reporting RP and CS, the following factors remained, reported in the same sequence as added to the model: frostbite affecting the hand (OR 12.44; 95% CI 5.84–26.52); heredity for RP (OR 4.03; 95% CI 2.17–7.46); BMI ≥ 25 kg/m2 (OR 0.27; 95% CI 0.16–0.45); upper extremity nerve injury (OR 2.23; 95% CI 1.29–3.85); and work with cold objects (OR 1.73; 95% CI 0.91–3.31). For cases reporting only RP, the final multiple model included the following factors: frostbite affecting the hands (OR 4.01; 95% CI 1.78–9.01); heredity for RP (OR 5.08; 95% CI 2.82–9.17); BMI ≥ 25 kg/m2 (OR 0.54; 95% CI 0.36–0.83); daily tobacco use (OR 1.57; 95% CI 0.96–2.57); heavily vibrating tools (OR 1.45; 95% CI 0.72–2.93); leisure-time cold exposure above the 50th percentile (OR 1.32; 95% CI 0.85–2.07); migraines (OR 0.56; 95% CI 0.25–1.22); and heredity for migraines (OR 1.35; 95% CI 0.83–2.20).

Analyses stratified by sex (Electronic supplementary material)

There were only minor differences when univariate analyses were stratified for sex for cases with RP and CS: vascular disease and migraines was only significant for men (OR 2.57; 95% CI 1.15–5.73 and OR 3.90; 95% CI 1.19–12.79, respectively), and rheumatic disease only for women (OR 2.75; 95% CI 1.05–7.25). Cumulative cold exposure was only significant for women (OR 1.63; 95% CI 1.04–2.56), and any HAV exposure only for men (OR 2.71; 95% CI 1.46–5.03).

Discussion

Key results

In the univariate analyses, those with RP and simultaneous CS showed associations to certain diseases and injuries (vascular disease; migraines; polyneuropathy; upper extremity nerve injury) and external factors (cold and occupational HAV exposure) that were not present among cases only reporting RP. In the multiple model, frostbite, heredity for RP and high BMI (protective) remained in both case groups, but upper extremity nerve injury only remained in the group reporting RP and CS. When comparing effect sizes in the multiple model, the odds ratio for frostbite was much higher among those reporting RP and CS compared to the other group (OR 12.44 and 4.01, respectively). Also, the effect of BMI seemed stronger in the RP and CS group compared to RP only (OR 0.27 and 0.54, respectively).

Interpretation and comparison

In our univariate analyses of the group reporting both RP and CS, there was a greater occurrence of diseases and injuries that are normally regarded as causes for secondary RP, such as vascular disease, cold injury and HAV syndrome [2, 3]. A number of these diseases and injuries have previously been reported in conjunction to CS alone, such as vascular disease [24], nerve injury [10], cold injury [25] and HAV syndrome [12]. Thus, it seems that CS and secondary RP share several common denominators, which suggest that CS is an acquired condition primarily arising as a result of peripheral neural or vascular injury. The peripheral nerves are supported by the vasa nervorum, a network of small blood vessels that provide perfusion from adjacent arteries, and this offers an explanation as to how vascular pathology could lead to neural injury. The basis for vascular pathology can be structural, such as in atherosclerotic disease, or functional as a result of vasospasm. In an angiographic study of 103 men and women suffering from bilateral RP without any established secondary cause, about half of them had obvious atherosclerotic changes and the other half vasospasm, showing that both can be present and contribute to the clinical picture [26]. However, apart from ischemic effects on nerves, it is also likely that a proportion of subjects may have autonomic neuropathy of other cause, which can predispose to vascular phenomena. An attack of RP is commonly associated with neurosensory symptoms, such as pain or paresthesia, and this has been described as a result of sensory nerve ischemia [27]. Research on cold injury, where CS is a prevalent sequelae, indicate that ischemic nerve injury from hypoperfusion may also play an important role in the etiology of CS [20]. We hypothesize that frequent ischemic episodes due to RP attacks, possibly in conjunction with other peripheral vascular and neural disease, can cause a long-lasting dysfunction in the peripheral sensory nerves of the hands, giving rise to the reporting of CS. The fact that upper extremity nerve injury was the only remaining factor that differed between case groups in our multiple model, offers additional support to the neural basis for CS.
The fact that migraines was only associated with RP with CS in the univariate analyses, and not with subjects only reporting RP, is a novel finding. A recent review [1] showed a strong association between migraines and primary RP (pooled OR 4.02; 95% CI 2.62–6.17) and the authors concluded that the pathophysiological background for migraines includes both vascular and neural events, with a paroxysmal nature similar to other vasospastic conditions, such as RP and variant angina, which have previously been shown to be associated to migraines [28]. Other authors have suggested that all three conditions may share a common underlying defect and could be characterized as a clinical syndrome of generalized arterial vasospasm [29, 30]. However, the role of vasoregulatory dysfunction in migraines has recently been downplayed, and a distinct mechanistic link is lacking [31]. Thus, the neural hypothesis in both CS and migraines, and their possible interplay, is a subject for further study.
Our data showed that being overweight was inversely related to reporting RP, while being underweight did not show any significant relation to our studied outcome, the latter most likely due to insufficient statistical power. Several previous studies have documented an inverse relationship between BMI and RP [24, 32, 33], and this finding could be explained by an increased amount of body fat having an insulating effect, maintaining both core and peripheral temperature.
Previous authors have reported smoking as a risk factor for RP [1], but this was not confirmed in our study. We investigated the current daily use of cigarettes or snuff, and it is likely that subjects suffering from RP would be encouraged by health care professionals to diminish or discontinue their use of tobacco, leading to an underestimation of the contribution of tobacco to the development of RP, and possibly CS, in our study. Neither could we establish an association between RP and the use of therapeutic drugs, including beta-adrenergic antagonists, oral contraceptives and hormone replacement therapies, which have previously been suggested as risk factors [1, 34]. However, we had a large amount of missing data (25.0%) in our questionnaire item about therapeutic drugs, which we believe was not missing at random since there were no checkbox for declaring no use, and this could have affected the reliability of analyses.
In our univariate analyses, a high cold exposure or handling of cold objects was significantly associated with reporting RP and CS, but not to only reporting RP. A previous French cross-sectional study showed that working in an environment with an ambient temperature below 15 °C for > 4 h per day, and handling cold objects and hand tools, was strongly associated with reporting RP [32]. Unfortunately, CS was not investigated in that study. Other studies have shown that patients with RP show a decreased perfusion of fingers during cold exposure [35] and have an increased risk of contracting cold injuries [36]. As described above, ischemic effects on peripheral nerves might then serve as an explanation for CS in heavily cold-exposed subjects with RP. However, whether cold exposure is a cause or mere trigger of RP, remains controversial [20].
Some authors have argued that epidemiologic studies on risk factors for RP should preferably be performed with men and women analyzed separately, since the pattern of risk factors may differ between the sexes [37]. However, the main purpose of this study was to distinguish between subjects with both RP and CS from those with only RP, rather than highlighting sex differences. For fullness, we provided supplemental sex-specific analyses in Online Appendix.

Strengths

This study represents a large population-based sample that explores a broad range of possible risk factors and introduces several interesting concepts regarding the background for RP and CS. Even though CS lacks a standardized definition, the clear difference in CISS and VAS results between cases with CS and other study participants support that our definition and inclusion criteria for CS were relevant. Since the questionnaires were administered during the cold winter period, the risk of recall bias regarding cold exposure was considered low.

Limits

One of the major limits of this study is that the nested case–control study design cannot be used to establish causal relations between individual and exposure factors and the disease states studied. However, it would be difficult to perform a longitudinal study with sufficient sample size and follow-up time. Another issue is that both RP and CS diagnoses were based on self-assessment, which limits the accuracy. Since our study does not investigate the reporting of CS in isolation, without concomitant RP, it is hard to distinguish which factors would be relevant only to the reporting of CS. However, an attempt to characterize CS more closely has previously been made on subjects selected from the same population [7]. The fact that the multiple model showed few remaining differences between the groups is suspected to be partly due to the covariance between the studied factors, for instance, that subjects who report previous frostbite could also be heavily exposed to ambient and contact cold. Further studies entailing longitudinal risk factor assessment, as well as objective evaluations of CS, are encouraged. Clinicians could benefit from separating CS from RP, since the etiology as well as the need for medical investigation may differ.

Conclusion

Raynaud’s phenomenon is strongly associated to previous cold injury, with a larger effect size among those who also report cold sensitivity. The fact that only upper extremity nerve injury differed significantly between case groups in our multiple model offers additional support to the neural basis for cold sensitivity.

Acknowledgements

We gratefully acknowledge the valuable contributions of Dr. Johan Nilsson Sommar at the Department of Public Health and Clinical Medicine at Umeå University.

Compliance with ethical standards

Conflict of interest

Albin Stjernbrandt, Hans Pettersson, Ingrid Liljelind, Tohr Nilsson and Jens Wahlström declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was approved by the Regional Ethical Review Board situated at Umeå University (DNR 2015-24-31M and 2014-286-31M).
Informed consent was obtained from all individual participants included in the study.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
3.
Zurück zum Zitat Ervasti O, Hassi J, Rintamäki H, Virokannas H, Kettunen P, Pramila S et al (2000) Sequelae of moderate finger frostbite as assessed by subjective sensations, clinical signs, and thermophysiological responses. Int J Circumpolar Health 59(2):137–145PubMed Ervasti O, Hassi J, Rintamäki H, Virokannas H, Kettunen P, Pramila S et al (2000) Sequelae of moderate finger frostbite as assessed by subjective sensations, clinical signs, and thermophysiological responses. Int J Circumpolar Health 59(2):137–145PubMed
4.
Zurück zum Zitat Sandqvist G, Eklund M, Åkesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33(2):102–107CrossRefPubMed Sandqvist G, Eklund M, Åkesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33(2):102–107CrossRefPubMed
9.
Zurück zum Zitat Lithell M, Backman C, Nyström A (1997) Pattern recognition in post-traumatic cold intolerance. J Hand Surg Br 22(6):783–787CrossRefPubMed Lithell M, Backman C, Nyström A (1997) Pattern recognition in post-traumatic cold intolerance. J Hand Surg Br 22(6):783–787CrossRefPubMed
17.
Zurück zum Zitat International Labour Organization (2012) International Standard Classification of Occupations (ISCO-08), Geneva, Switzerland. ISBN 978-92-2-125953-4 International Labour Organization (2012) International Standard Classification of Occupations (ISCO-08), Geneva, Switzerland. ISBN 978-92-2-125953-4
18.
Zurück zum Zitat Wewers ME, Lowe NK (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13(4):227–236CrossRef Wewers ME, Lowe NK (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13(4):227–236CrossRef
20.
Zurück zum Zitat Thomas J, Oakley EH (2001) Nonfreezing cold injury. In: Pandolf K, Burr R (eds) Textbook of military medicine, medical aspects of harsh environments, vol 1. US Army, Washington, pp 467–490 Thomas J, Oakley EH (2001) Nonfreezing cold injury. In: Pandolf K, Burr R (eds) Textbook of military medicine, medical aspects of harsh environments, vol 1. US Army, Washington, pp 467–490
23.
Zurück zum Zitat McCabe SJ, Mizgala C, Glickman L (1991) The measurement of cold sensitivity of the hand. J Hand Surg Am 16(6):1037–1040CrossRefPubMed McCabe SJ, Mizgala C, Glickman L (1991) The measurement of cold sensitivity of the hand. J Hand Surg Am 16(6):1037–1040CrossRefPubMed
24.
Zurück zum Zitat Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Palesch Y, Biro C et al (1997) Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison. J Rheumatol 24(5):879–889PubMed Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Palesch Y, Biro C et al (1997) Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison. J Rheumatol 24(5):879–889PubMed
26.
Zurück zum Zitat van Vugt RM, Kater L, Dijkstra PF, Schardijn GH, Kastelein JJ, Bijlsma JW (2003) The outcome of angiography in patients with Raynaud’s phenomenon: an unexpected role for atherosclerosis and hypercholesterolemia. Clin Exp Rheumatol 21(4):445–450PubMed van Vugt RM, Kater L, Dijkstra PF, Schardijn GH, Kastelein JJ, Bijlsma JW (2003) The outcome of angiography in patients with Raynaud’s phenomenon: an unexpected role for atherosclerosis and hypercholesterolemia. Clin Exp Rheumatol 21(4):445–450PubMed
28.
Zurück zum Zitat O’Keeffe ST, Tsapatsaris NP, Beetham WP Jr (1992) Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med 116(12 Pt 1):985–989CrossRefPubMed O’Keeffe ST, Tsapatsaris NP, Beetham WP Jr (1992) Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med 116(12 Pt 1):985–989CrossRefPubMed
31.
Zurück zum Zitat Hummers LK (2015) Systemic vasospasm. In: Wigley FM, Herrick AL, Flavahan NA (eds) Raynaud’s phenomenon: a guide to pathogenesis and treatment, 1st edn. Springer, New York, pp 267–278 Hummers LK (2015) Systemic vasospasm. In: Wigley FM, Herrick AL, Flavahan NA (eds) Raynaud’s phenomenon: a guide to pathogenesis and treatment, 1st edn. Springer, New York, pp 267–278
33.
Zurück zum Zitat Keil JE, Maricq HR, Weinrich MC, McGregor AR, Diat F (1991) Demographic, social and clinical correlates of Raynaud phenomenon. Int J Epidemiol 20(1):221–224CrossRefPubMed Keil JE, Maricq HR, Weinrich MC, McGregor AR, Diat F (1991) Demographic, social and clinical correlates of Raynaud phenomenon. Int J Epidemiol 20(1):221–224CrossRefPubMed
36.
Zurück zum Zitat Mäkinen TM, Jokelainen J, Näyhä S, Laatikainen T, Jousilahti P, Hassi J (2009) Occurrence of frostbite in the general population—work-related and individual factors. Scand J Work Environ Health 35(5):384–393CrossRefPubMed Mäkinen TM, Jokelainen J, Näyhä S, Laatikainen T, Jousilahti P, Hassi J (2009) Occurrence of frostbite in the general population—work-related and individual factors. Scand J Work Environ Health 35(5):384–393CrossRefPubMed
37.
Zurück zum Zitat Fraenkel L (2002) Raynaud’s phenomenon: epidemiology and risk factors. Curr Rheumatol Rep 4(2):123–128CrossRefPubMed Fraenkel L (2002) Raynaud’s phenomenon: epidemiology and risk factors. Curr Rheumatol Rep 4(2):123–128CrossRefPubMed
Metadaten
Titel
Raynaud’s phenomenon in Northern Sweden: a population-based nested case–control study
verfasst von
Albin Stjernbrandt
Hans Pettersson
Ingrid Liljelind
Tohr Nilsson
Jens Wahlström
Publikationsdatum
20.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 2/2019
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4133-y

Weitere Artikel der Ausgabe 2/2019

Rheumatology International 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.